Risk of complications during intravenous heparin therapy

Area of Science:

• Pharmacology
• Clinical Medicine
• Cardiovascular Research

Background:

• Heparin is a widely used anticoagulant.
• Understanding the safety profile of continuous intravenous heparin infusion is crucial for patient care.

Purpose of the Study:

• To evaluate the safety and complication rates associated with continuous intravenous heparin administration.
• To identify patient factors contributing to heparin-related complications.

Main Methods:

• Retrospective review of 131 patients receiving continuous intravenous heparin infusion (porcine heparin) over 10,000 units/24 hours for at least 24 hours.
• Data collected included patient demographics, heparin dosage, and complication events.
• Activated partial thromboplastin time (aPTT) was the primary monitoring test.

Main Results:

• Overall complication rate was 17.6% (10% major, 7.6% minor).
• All major complications occurred in patients with serious concurrent diseases.
• No major complications were observed in patients without concurrent disease or those where heparin was initiated for unconfirmed thromboembolism.

Conclusions:

• Continuous intravenous heparin infusion is associated with minimal risk.
• Risk of complications is significantly higher in older patients with severe concurrent medical conditions.
• Careful patient selection and monitoring can optimize heparin therapy safety.